The global Tissue Diagnostics Market size is expected to reach USD 14.03 billion by 2030, registering a CAGR of 8.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to a lack of skilled pathologists has driven the tissue diagnostics industry. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplements the market growth.
The
use of digital slides has significantly increased in recent years, owing to its
associated benefits including flexible magnification and remote access to
slides. The growing emphasis on precision medicine is supported by several
organizations & companies in the U.S., which is expected to contribute to
the market growth. Additionally, companies are supporting the development of
precision medicine with novel oncology solutions. For instance, in May 2020,
QIAGEN launched new oncology solutions, such as the QCI Interpret One software
solution for genomic profiling of tumors. The advancements in imaging
techniques are expected to positively influence market growth.
In addition,
one of the emerging trends in the tissue diagnostics industry is the
integration of digital pathology and artificial intelligence (AI). Digital pathology
involves the scanning and digitization of tissue slides, allowing pathologists
to review and analyze images remotely. AI algorithms can then be applied to
these digital images to aid in the interpretation and analysis of tissue samples.
This integration enables faster and more accurate diagnoses, enhances workflow
efficiency, and improves patient care. It also facilitates the development of
predictive models and precision medicine approaches. As a result, there is a
growing demand for digital pathology solutions and AI-driven tissue diagnostics
platforms in the market.
With
technological improvements in imaging techniques, the sensitivity of detection
and diagnosis of breast cancer has also improved. For instance, in May 2023,
with an emphasis on AI-guided breast cancer diagnoses, BPGbio recently
announced an agreement with the Department of Defense (DoD). The new panel,
created with artificial intelligence, is intended to detect women diagnosed
with ER+ breast cancer but do not react to hormone therapy, allowing for more
suitable treatment alternatives and improving treatment response.
The
unique 34-gene breast cancer diagnostic panel from BPGbio will also receive
wider evaluation through the Interrogative Biology Platform, focusing on ER+
breast cancers, which are significantly rising. Technological expansion in
breast tissue analysis includes procedures for evaluating gene expression,
cellular biochemistry, and molecular biology using digital methods,
tomosynthesis, CAD, and other methods.
List of Key Players in the Tissue Diagnostics Market
- F.
Hoffmann-La Roche Ltd.
- Abbott
Laboratories
- Thermo
Fisher Scientific Inc.
- Siemens
- Danaher
- bioMérieux
SA
- QIAGEN
- BD
- Merck KGaA
- GE
Healthcare
- BioGenex
- Cell
Signaling Technology, Inc.
- Bio SB
- DiaGenic ASA
- Agilent
Technologies
Request a
free sample copy or view report summary: Tissue Diagnostics Market Report
Tissue Diagnostics Market Report Highlights
- The
immunohistochemistry segment dominated the market in terms of revenue
share of 25.79% in 2024. Immunohistochemistry (IHC) is a special staining
test in which a diagnostic antibody is bound to a specific target protein
present in cell membranes or cells on slides containing tissue samples.
- The digital
pathology and workflow segment is anticipated to grow at the fastest CAGR
of 12.22%. Digital pathology and workflow integration have revolutionized
the application of ISH by enhancing imaging, data management, and
analysis.
- The breast
cancer segment held the largest market share of 50.45% in 2024 and is
anticipated to grow at the fastest CAGR. The increasing incidence of
breast cancer due to lifestyle changes and rapidly aging global population
provide lucrative growth opportunities for the segment.
- The clinical
market segment dominated the market in 2024 and is anticipated to grow at
the fastest CAGR of 8.83% over the forecast period, driven by advancements
in medical technology, increasing disease prevalence, and a rising demand
for precise & personalized medicine.
- The
hospitals dominated the market with the largest revenue share of 37.82% in
2024. The usage of tissue diagnostic systems and services in hospitals
& clinics has increased over the years. In several hospitals and
clinics, physicians are switching to tissue diagnostic tests from
conventional testing procedures.
- North
America tissue diagnostics market accounted for a 44.76% share in 2024,
driven by a rising demand for advanced diagnostic tools due to the
increasing prevalence of cancer and other diseases.
Related Press Release@ Tissue
Diagnostics Industry Analysis
Tissue Diagnostics Market Segmentation
Grand
View Research has segmented the global tissue diagnostics market on the basis
of on technology, modality, application, end-use, and region:
Tissue Diagnostics Technology Outlook (Revenue, USD
Million; 2018 - 2030)
- Immunohistochemistry
- Instruments
- Slide
Staining Systems
- Tissue
Microarrays
- Tissue
Processing Systems
- Slide
Scanners
- Cell
Processors
- Microtomes
- Embedding
Systems
- Cover
Slippers
- Other
Products
- Consumables
- H&E
Stainer Coverslipper
- IHC
Stainer Coverslipper
- Antibodies
- Others IHC
reagents
- In Situ
Hybridization
- Instruments
- Stainers
- Others
- Total
- Consumables
- Software
- Primary
& Special Staining
- Digital
Pathology And Workflow
- Image
Analysis Informatics
- Information
Management System Storage & Communication
- Anatomic
Pathology
- Instruments
- Microtomes
& Cryostat Microtomes
- Tissue
Processors
- Automatic
Strainers
- Other
Products
- Consumables
- Reagents
& Antibodies
- Probes
& Kits
- Others
- Molecular
Pathology
- Instruments
- Reagents
- Fluorescence
Reagents
- Others
- Others
Tissue Diagnostics Application Outlook (Revenue, USD
Million; 2018 - 2030)
- Breast
Cancer
- Non-small
Cell Lung Cancer
- Prostate
Cancer
- Gastric
Cancer
- Other
Cancers
Tissue Diagnostics Modality Outlook (Revenue, USD
Million; 2018 - 2030)
- Clinical
- Pharma / CRO
/ Research Market
Tissue Diagnostics End-use Outlook (Revenue, USD
Million; 2018 - 2030)
- Hospitals
- Diagnostic
Center
- Pharmaceutical
Organizations
- Contract
Research Organizations (CROs)
Tissue Diagnostics Regional Outlook (Revenue, USD
Million; 2018 - 2030)
- North
America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- Spain
- France
- Italy
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin
America
- Brazil
- Argentina
- Middle East
and Africa (MEA)
- South
Africa
- Saudi
Arabia
- UAE
- Kuwait
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment